Bayer’s Agfa division reported its fiscal 1998 results last month. Agfa saw sales rise by 5% to DM 8.5 billion ($4.7 billion), as compared with DM 8.1 billion ($4.5 billion) in 1997. Its operating profit declined by 12.9% to $2.7 million, which the
Bayers Agfa division reported its fiscal 1998 results last month. Agfa saw sales rise by 5% to DM 8.5 billion ($4.7 billion), as compared with DM 8.1 billion ($4.5 billion) in 1997. Its operating profit declined by 12.9% to $2.7 million, which the company attributed to the Asian financial crisis.
Sales in Agfas technical imaging systems division climbed 8% in 1998 as compared with 1997, from $993 million to $1 billion. The groups medical business unit contributed about three-quarters of the divisions sales, Bayer said. In January, Agfa moved to acquire Sterling Diagnostic Imaging (SCAN 1/20/99), and the purchase should be completed this spring, according to the company.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.